127 related articles for article (PubMed ID: 9827060)
1. Proscar (Finasteride) inhibits 5 alpha-reductase activity in the ovaries and testes of Lytechinus variegatus Lamarck (Echinodermata: Echinoidea).
Wasson KM; Watts SA
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Oct; 120(3):425-31. PubMed ID: 9827060
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of testosterone and 5alpha-androstanediols during nutritionally stimulated gonadal growth in Lytechinus variegatus lamarck (Echinodermata:Echinoidea).
Wasson KM; Hines GA; Watts SA
Gen Comp Endocrinol; 1998 Aug; 111(2):197-206. PubMed ID: 9679091
[TBL] [Abstract][Full Text] [Related]
3. Levels of progesterone, testosterone, and estradiol, and androstenedione metabolism in the gonads of Lytechinus variegatus (Echinodermata:echinoidea).
Wasson KM; Gower BA; Hines GA; Watts SA
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jun; 126(2):153-65. PubMed ID: 11050687
[TBL] [Abstract][Full Text] [Related]
4. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
5. Progesterone metabolism in the ovaries and testes of the echinoid Lytechinus variegatus Lamarck (Echinodermata).
Wasson KM; Watts SA
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Dec; 127(3):263-72. PubMed ID: 11246497
[TBL] [Abstract][Full Text] [Related]
6. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
7. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
[TBL] [Abstract][Full Text] [Related]
8. Effects of the anti-androgen finasteride on 5 alpha-reduction of androgens in the presence of progesterone in human gingival fibroblasts: modulatory actions of the alkaline phosphatase inhibitor levamisole.
Tilakaratne A; Soory M
J Periodontal Res; 2000 Aug; 35(4):179-85. PubMed ID: 10983877
[TBL] [Abstract][Full Text] [Related]
9. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
[TBL] [Abstract][Full Text] [Related]
10. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
Prahalada S; Rhodes L; Grossman SJ; Heggan D; Keenan KP; Cukierski MA; Hoe CM; Berman C; van Zwieten MJ
Prostate; 1998 May; 35(3):157-64. PubMed ID: 9582084
[TBL] [Abstract][Full Text] [Related]
11. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
12. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.
Rittmaster RS; Manning AP; Wright AS; Thomas LN; Whitefield S; Norman RW; Lazier CB; Rowden G
Endocrinology; 1995 Feb; 136(2):741-8. PubMed ID: 7835306
[TBL] [Abstract][Full Text] [Related]
13. Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.
Nguyen QH; Chen T; Wang X; Chen Y; Chien P
Int J Dermatol; 1995 Oct; 34(10):720-5. PubMed ID: 8537164
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.
Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A
Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882
[TBL] [Abstract][Full Text] [Related]
15. 5 alpha-reductase inhibitors, chemical and clinical models.
Guarna A; Occhiato EG; Danza G; Conti A; Serio M
Steroids; 1998; 63(5-6):355-61. PubMed ID: 9618802
[TBL] [Abstract][Full Text] [Related]
16. Effect of finasteride on human testicular steroidogenesis.
Castro-Magana M; Angulo M; Fuentes B; Canas A; Sarrantonio M; Arguello R; Vitollo P
J Androl; 1996; 17(5):516-21. PubMed ID: 8957695
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
18. Potential activities of androgen metabolizing enzymes in human prostate.
Krieg M; Weisser H; Tunn S
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
[TBL] [Abstract][Full Text] [Related]
19. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
Weisser H; Krieg M
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
